中商官网
研究报告
皓元医药（688131）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 58623500.0000 | 1946600.0000 | 2574800.0000 | 2324400.0000 | 34492000.0000 | 24795100.0000 | 9696800.0000 |
| 2014 | 67087300.0000 | 1540100.0000 | 2999100.0000 | 3151200.0000 | 57386100.0000 | 24284500.0000 | 33101600.0000 |
| 2015 | 91932900.0000 | 7643200.0000 | 9169900.0000 | 8535800.0000 | 74456900.0000 | 41803700.0000 | 32653100.0000 |
| 2016 | 117000000.0000 | 17196000.0000 | 20215400.0000 | 18020400.0000 | 156000000.0000 | 100000000.0000 | 55979200.0000 |
| 2017 | 174000000.0000 | 16170800.0000 | 16169100.0000 | 15006900.0000 | 192000000.0000 | 76940100.0000 | 115000000.0000 |
| 2018 | 300000000.0000 | 23962600.0000 | 24002400.0000 | 18414200.0000 | 304000000.0000 | 127000000.0000 | 178000000.0000 |
| 2019 | 409000000.0000 | 84382900.0000 | 84357300.0000 | 73429600.0000 | 542000000.0000 | 143000000.0000 | 400000000.0000 |
| 2020 | 635000000.0000 | 149000000.0000 | 149000000.0000 | 128000000.0000 | 857000000.0000 | 329000000.0000 | 528000000.0000 |
| 2021 | 969000000.0000 | 210000000.0000 | 210000000.0000 | 191000000.0000 | 2385000000.0000 | 548000000.0000 | 1836000000.0000 |
| 2022 | 1358000000.0000 | 197000000.0000 | 199000000.0000 | 192000000.0000 | 3598000000.0000 | 1266000000.0000 | 2332000000.0000 |
| 2023 | 1880000000.0000 | 128000000.0000 | 128000000.0000 | 126000000.0000 | 4192000000.0000 | 1666000000.0000 | 2526000000.0000 |
| 2024 | 2270000000.0000 | 237000000.0000 | 238000000.0000 | 198000000.0000 | 5505000000.0000 | 2601000000.0000 | 2904000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 2.22 | 4.39 | 7.46 | 27.8800 | 2.8300 | 11.48 | 1.70 |
| 2014 | 2.30 | 4.47 | 5.23 | 27.9500 | 3.1200 | 11.41 | 1.17 |
| 2015 | 8.31 | 9.97 | 12.32 | 22.8900 | 3.2000 | 9.10 | 1.23 |
| 2016 | 14.63 | 17.28 | 12.96 | 40.6200 | 1.6100 | 6.01 | 0.75 |
| 2017 | 5.75 | 9.29 | 8.42 | 17.3100 | 1.1500 | 7.45 | 0.91 |
| 2018 | 6.00 | 8.00 | 7.90 | 14.6700 | 1.3700 | 9.96 | 0.99 |
| 2019 | 18.83 | 20.63 | 15.56 | 21.5500 | 1.3000 | 8.97 | 0.75 |
| 2020 | 21.42 | 23.46 | 17.39 | 27.6700 | 1.4500 | 9.59 | 0.74 |
| 2021 | 20.12 | 21.67 | 8.81 | 16.2800 | 1.5300 | 8.64 | 0.41 |
| 2022 | 11.63 | 14.65 | 5.53 | 9.9000 | 1.0400 | 5.65 | 0.38 |
| 2023 | 5.90 | 6.81 | 3.05 | 5.2200 | 1.0000 | 4.78 | 0.45 |
| 2024 | 9.74 | 10.48 | 4.32 | 7.6100 | 1.0200 | 4.67 | 0.41 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 71.89 | 28.11 | 1.2700 | 0.3700 |
| 2014 | 42.32 | 57.68 | 2.1500 | 1.2500 |
| 2015 | 56.14 | 43.86 | 1.5700 | 0.8300 |
| 2016 | 64.10 | 35.88 | 1.4900 | 0.8200 |
| 2017 | 40.07 | 59.90 | 2.2900 | 1.0200 |
| 2018 | 41.78 | 58.55 | 2.3600 | 1.1900 |
| 2019 | 26.38 | 73.80 | 3.4400 | 2.1700 |
| 2020 | 38.39 | 61.61 | 2.1600 | 1.3400 |
| 2021 | 22.98 | 76.98 | 4.9400 | 3.7200 |
| 2022 | 35.19 | 64.81 | 2.2200 | 1.0400 |
| 2023 | 39.74 | 60.26 | 1.8800 | 0.8600 |
| 2024 | 47.25 | 52.75 | 2.5200 | 1.5500 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 57324800.0000 | 2054800.0000 | 9621300.0000 | 272400.0000 |
| 2014 | 65547200.0000 | 2701500.0000 | 11954400.0000 | 464200.0000 |
| 2015 | 84289700.0000 | 4252100.0000 | 15792900.0000 | 361100.0000 |
| 2016 | 99885000.0000 | 9057100.0000 | 27865700.0000 | 631000.0000 |
| 2017 | 164000000.0000 | 18564400.0000 | 22608700.0000 | 527700.0000 |
| 2018 | 282000000.0000 | 32250200.0000 | 54285500.0000 | 2236800.0000 |
| 2019 | 332000000.0000 | 47142400.0000 | 42528400.0000 | 1612200.0000 |
| 2020 | 499000000.0000 | 49019500.0000 | 65878800.0000 | 9390100.0000 |
| 2021 | 774000000.0000 | 69600200.0000 | 114000000.0000 | 15879700.0000 |
| 2022 | 1200000000.0000 | 110000000.0000 | 169000000.0000 | 6389900.0000 |
| 2023 | 1769000000.0000 | 158000000.0000 | 220000000.0000 | 31850100.0000 |
| 2024 | 2049000000.0000 | 210000000.0000 | 235000000.0000 | 36410100.0000 |